ZTS - Up 100% in a Year Can This Animal Health Stock Keep Climbing?
Animal healthcare is an interesting market sector. In 2013, Pfizer spun out its animal health division, Zoetis (NYSE: ZTS) , and the newborn stock proceeded to stomp its parent company into the dirt. Pfizer's stock has gone up 54% since the spinoff, while Zoetis has romped to a 465% market return. (So if Merck or Bayer decides to spin off its animal health division one day, investors might want to pay attention.)
While the pharmaceutical side of animal healthcare has seen robust growth, that's nothing compared to what's happening in the diagnostic sector. The big company here (with a $47 billion market cap) is Idexx Laboratories (NASDAQ: IDXX) -- its stock has zoomed 1,000% over the last decade. But even that pales in comparison to tiny little Heska (NASDAQ: HSKA) , which has run up an amazing 2,000% in 10 years.
Animal health stocks are on fire! What's up with that? Let's dive in.
For further details see:
Up 100% in a Year, Can This Animal Health Stock Keep Climbing?